For example, it was reported that plasma PAI-1 level was increased in CRC patients with liver metastasis, and PAI-1 silencing may suppress colorectal cancer progression and liver metastasis in vitro and in vivo [20]. This evidence concerns the gene SERPINE1 and colorectal carcinoma.